5 Members•3,500 Posts

biotech

First human trial of cellular reprogramming approved in bid to treat blindness

Feb 1, 2026

Ian Lyall

Nvidia signals record OpenAI investment while distancing itself from $100bn figure

Jan 31, 2026

Ian Lyall

Eli Lilly to build $3.5bn weight-loss drug facility in Pennsylvania

Jan 30, 2026

TechDefused Newsroom

Hims & Hers to air national Big Game ad highlighting healthcare access gap

Jan 29, 2026

TechDefused Newsroom

MoltBot Explained: The viral AI agent formerly ClawdBot

Jan 28, 2026

Ian Lyall

HBO Max unveils February slate of originals, films and live sports

Jan 26, 2026

TechDefused Newsroom

10X Health and Verséa unveil mitochondrial test developed from NASA research

Jan 26, 2026

TechDefused Newsroom

Google.org awards $20m to AI-led science projects tackling health, energy and biodiversity

Jan 26, 2026

TechDefused Newsroom

Biology’s new supply chains: Why the future of biotech may be manufacturing, not discovery

Jan 20, 2026

Ian Lyall

The end of antibiotics, again: phage therapy, bacteriocins, and precision antimicrobials

Jan 20, 2026

Ian Lyall

The immune system’s new teachers: Personalised cancer vaccines and the logistics of made-to-order medicine

Jan 20, 2026

Ian Lyall

Batteries, not brains: Bioelectricity and the new map of how bodies heal

Jan 20, 2026

Ian Lyall

CRISPR’s next act: Editors that rewrite single letters without cutting the DNA

Jan 20, 2026

Ian Lyall

The cell’s postal service: How extracellular vesicles could become the next drug delivery revolution

Jan 20, 2026

Ian Lyall

Living medicines, strange ethics: the rise of engineered microbes that treat disease from the inside

Jan 20, 2026

Ian Lyall

Organoids on a chip: Miniature human tissues that are changing how drugs are tested

Jan 20, 2026

Ian Lyall

The quiet revolution in protein design: Enzymes and binders made by algorithms, built in yeast

Jan 20, 2026

Ian Lyall

New antibiotics explained: Phages, bacteriocins and AI, and why none is a silver bullet

Jan 18, 2026

Ian Lyall

Biofoundries explained: Inside the robot labs, engineering biology at industrial scale

Jan 18, 2026

Ian Lyall

CRISPR delivery explained: Why editing DNA is easier than getting the editor to the right cells

Jan 18, 2026

Ian Lyall

Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy